Aeluma (NASDAQ:ALMU) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Aeluma (NASDAQ:ALMU) posted its quarterly earnings data on Wednesday. The company reported ($0.04) earnings per share for the quarter, topping the consensus estimate of ($0.05) by $0.01, FiscalAI reports. The company had revenue of $1.22 million for the quarter, compared to analysts’ expectations of $1.37 million. Aeluma had a negative net margin of 52.48% and a negative return on equity of 8.15%.

Here are the key takeaways from Aeluma’s conference call:

• Aeluma said customer interest accelerated after OFC, especially in AI datacom, where supply constraints around lasers and indium phosphide substrates are creating near-term opportunities for its non-indium phosphide photonics.
• The company highlighted its high-speed InGaAs photodiodes and quantum dot lasers as key products, arguing they can help customers overcome performance, power, reliability, and packaging bottlenecks in data center applications.
• Aeluma reported it has secured 6 government development contracts this fiscal year, exceeding its goal of 3 to 7 and bringing in more than $5 million in non-dilutive funding.
• Fiscal third-quarter revenue was $1.2 million, while GAAP net loss was $1.8 million and non-GAAP net loss was $701,000. The company ended the quarter with $37.8 million in cash and no long-term debt.
• Aeluma narrowed full-year revenue guidance to $4.2 million to $4.6 million from $4 million to $6 million, citing delays in government contract execution and shutdown-related timing shifts.

Aeluma Trading Down 15.4%

ALMU stock traded down $4.84 during midday trading on Thursday, hitting $26.65. The company’s stock had a trading volume of 5,215,354 shares, compared to its average volume of 1,101,127. The company has a market cap of $479.78 million, a PE ratio of -190.34 and a beta of 4.49. The firm’s 50-day moving average is $16.94 and its 200-day moving average is $16.54. Aeluma has a 12 month low of $10.20 and a 12 month high of $31.79.

Insider Activity

In other news, Director Steven Denbaars sold 12,500 shares of the stock in a transaction that occurred on Wednesday, February 25th. The shares were sold at an average price of $17.58, for a total value of $219,750.00. Following the transaction, the director owned 397,588 shares in the company, valued at $6,989,597.04. This represents a 3.05% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Jonathan Klamkin sold 50,000 shares of the firm’s stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $18.05, for a total value of $902,500.00. Following the completion of the transaction, the chief executive officer directly owned 1,429,398 shares in the company, valued at approximately $25,800,633.90. This represents a 3.38% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 102,500 shares of company stock worth $1,883,450 in the last 90 days. Company insiders own 14.70% of the company’s stock.

Institutional Investors Weigh In On Aeluma

A number of institutional investors and hedge funds have recently bought and sold shares of the business. XTX Topco Ltd bought a new stake in Aeluma during the fourth quarter valued at about $247,000. Quadrature Capital Ltd raised its position in shares of Aeluma by 61.3% during the fourth quarter. Quadrature Capital Ltd now owns 20,711 shares of the company’s stock valued at $356,000 after buying an additional 7,871 shares during the last quarter. &PARTNERS raised its position in shares of Aeluma by 6.5% during the fourth quarter. &PARTNERS now owns 15,057 shares of the company’s stock valued at $259,000 after buying an additional 923 shares during the last quarter. Squarepoint Ops LLC bought a new stake in shares of Aeluma during the fourth quarter valued at approximately $320,000. Finally, Barclays PLC raised its position in shares of Aeluma by 106.7% during the fourth quarter. Barclays PLC now owns 28,748 shares of the company’s stock valued at $494,000 after buying an additional 14,841 shares during the last quarter.

Analysts Set New Price Targets

Several research analysts recently commented on the stock. Freedom Capital raised shares of Aeluma to a “strong-buy” rating in a research note on Tuesday, March 31st. Benchmark reissued a “buy” rating and issued a $25.00 target price on shares of Aeluma in a research note on Tuesday, March 3rd. Weiss Ratings reissued a “sell (d-)” rating on shares of Aeluma in a research note on Monday, April 20th. Williams Trading set a $25.00 price target on shares of Aeluma in a report on Tuesday, March 3rd. Finally, UBS Group reiterated a “buy” rating on shares of Aeluma in a report on Tuesday, March 3rd. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $25.33.

Aeluma Company Profile

Aeluma, Inc develops optoelectronic and electronic devices in the United States. The company manufactures semiconductor materials and chips using compound semiconductors on diameter substrates that are used to manufacture mass market microelectronics. It offers its devices for use in mobile, automotive, AI, defence and aerospace, communication, AR/VR, and HPC applications, as well as laser emitters, transistors for integrated circuits, quantum photonic circuits, and solar cells applications. Aeluma, Inc was formerly known as Parc Investments, Inc and changed its name to Aeluma, Inc June 2021.